In the past decade, diabetes treatment - which long required fingerprick testing and insulin injections - has been revolutionised by automated insulin pumps, like the Omnipod. But the rollout has been accompanied by a dramatic increase in the number of adverse event reports linked to the devices, as TGA comes under question for approval process.